Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sectoral funds – Weekly roundup - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Sep 16, 2000

    Sectoral funds – Weekly roundup

    The markets slipped moderately this week. The BSE fell 2.2% to close at 4,562 points, while the S&P CNX Nifty slid 2.4% to close at 1,417 points.

    Open-ended, IT Fnds NAV
    Pru ICICI Tech. (Gr) 6.5 2.7% 23.1% 0.0% -34.0%
    Alliance New Millenn (Gr) 9.6 2.6% 27.8% 0.0% -37.5%
    UTI Sector- Software 24.5 1.2% 24.5% 88.1% 87.8%
    Birla IT Fund (Gr) 20.3 0.3% 19.2% 50.2% 15.1%
    DSP ML Tech.com (Gr) 9.2 -0.1% 22.8% 0.0% 8.0%
    Tata IT Sector Fund 12.7 -0.2% 18.6% 65.2% 25.7%
    Magnum Sector Funds-IT 17.7 -0.7% 22.5% 100.2% 125.0%
    K P Infotech (Gr) 31.1 -0.7% 14.7% 111.9% 149.0%
    K P Internet Opport.(Gr) 8.5 -0.8% 12.5% 0.0% -11.7%
    IL&FS eCOM Fund (Gr) 7.0 -0.8% 24.5% 0.0% -48.6%
    K Tech 8.2 -1.0% 18.1% 0.0% 4.1%
    Chola Freedom Tech (Reg) 10.4 -5.7% 11.6% 8.5% 20.0%

    The last days of the week saw some selling in software stocks, which had appreciated reasonably. This pulled down net asset values (NAVs) of IT funds, reversing the trend we have witnessed over the past few weeks. As prices of software stocks decline, there could be buying this week as funds try to exploit trading opportunities and this could push up NAVs of IT funds.

    Open-ended, Pharma Funds NAV
    UTI Sector-Pharma 10.4 -0.6% 7.7% -13.0% -13.0%
    Magnum Sector Funds-Pharma 9.9 -1.6% 4.9% -15.2% -1.2%
    K P Pharma (Gr) 10.1 -2.1% 6.2% -17.2% 6.0%

    Selling in Indian pharma stocks (Ranbaxy, Dr Reddys’, Cipla) resulted in a slide in NAVs of pharma funds. MNC pharma stocks were at previous levels. There is no sustained buying (or selling) of pharma stocks, which is mainly due to the fact that stocks are range-bound, and this has affected NAVs of pharma funds.

    Open-ended, FMCG Funds NAV
    K P FMCG (Gr) 12.4 1.6% 6.3% -1.1% 18.8%
    Pru ICICI FMCG (Gr) 10.2 0.7% 5.0% -10.9% -0.5%
    Magnum Sector Funds-FMCG 9.0 -5.5% 9.5% -22.4% -11.5%

    FMCG stocks moved up marginally and this has resulted in a surge in NAVs of FMCG funds. However there was some selling in FMCG stocks yesterday. Even at 12-month lows, there are no buyers for FMCG stocks, which is mainly why FMCG funds are going nowhere.



    Equitymaster requests your view! Post a comment on "Sectoral funds – Weekly roundup". Click here!


    More Views on News

    The Right Financial Advisor Is Around the Corner (Outside View)

    Mar 10, 2016

    An opportunity to find an impeccably trustworthy and competent financial guardian is in the offing.

    Why financial planning should be dull and boring (Mutual Fund Corner)

    Feb 29, 2016

    Most financial planners come out as whiz kids who throw around financial jargon. But financial planning can be actually easy, provided one follows a disciplined approach.

    What Are E-Wallets And How To Use Them (Mutual Fund Corner)

    Feb 12, 2016

    PersonalFN highlights the benefits of parking a portion of your expenses in e-wallets and using them efficiently.

    Is Consumption Boom Over In India? (Mutual Fund Corner)

    Feb 2, 2016

    Mutual funds take a bearish call on the FMCG sector. The sector has started playing out due to a combination of slower growth and expensive valuations.

    How to Find a Saint Amongst Sinners? (Mutual Fund Corner)

    Feb 1, 2016

    Ethical practices help build long lasting relationships, and healthy long-term business relationships are often mutually rewarding. But PersonalFN is of the view that the financial services industry in India seems to have forgotten this.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

    Aug 21, 2017

    Most Indians who cannot find jobs, look at becoming self-employed.

    It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

    Aug 16, 2017

    The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

    Aug 22, 2017

    Post demonetisation, a cut in bank savings deposits rates was in the offing.

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms